Ginsenoside Rg1 inhibits tumor necrosis factor-alpha (TNF-alpha)-induced human arterial smooth muscle cells (HASMCs) proliferation

Journal of Cellular Biochemistry
Hong-Sheng Zhang, Sheng-Qi Wang

Abstract

In China, the ginseng root began to be used in medicine over 2000 years ago. Ginsenosides are the most important component isolated from ginseng. The aim of this study was to determine the effects of ginsenoside Rg1 on the proliferation and molecular mechanism in cultured human arterial vascular smooth muscle cell (HASMC) induced by tumor necrosis factor-alpha (TNF-alpha). It was shown that ginsenoside Rg1 significantly inhibited TNF-alpha-induced HASMC proliferation in a dose-dependent manner. Treatment with ginsenoside Rg1, which blocked the cell cycle in the G1-phase, induced a downregulation of cyclin D1 and an upregulation in the expression of p53, p21(WAF/CIP1), and p27(KIP1). MEK inhibitors PD98059, U0126, and phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin, but not p38-inhibitor SB203580 or JNK-inhibitor SP600125 significantly aggravated ginsenoside Rg1-inhibited HASMC proliferation. Ginsenoside Rg1 markedly inactivated the extracellular signal-regulated kinases (ERK1/2) and protein kinase B (PKB), indicating that the inhibition of ginsenoside Rg1 on HASMC proliferation was associated with ERK and PI3K/PKB pathways. The inactivation of ERK and PI3K/PKB pathways and modulation of cell-cycle proteins by ginsenos...Continue Reading

References

Feb 20, 1986·The New England Journal of Medicine·R Ross
Jun 1, 1984·British Journal of Pharmacology·X ChenR Moalli
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·S Y NahE W McCleskey
Jan 1, 1995·Annual Review of Physiology·R Ross
Nov 18, 1994·Cell·C J Sherr
Aug 23, 1996·The Journal of Biological Chemistry·J N LavoieJ Pouysségur
Aug 1, 1996·Clinical and Experimental Pharmacology & Physiology·X Chen
Jul 1, 1997·Biochemical Pharmacology·C N Gillis
Jan 14, 1999·The New England Journal of Medicine·R Ross
Nov 26, 1999·Biochemical Pharmacology·A S AtteleC S Yuan
Mar 10, 2001·Journal of Cellular Physiology·P R Yew
Mar 10, 2001·Nature·L Chang, M Karin
Jan 24, 2002·The Journal of Biological Chemistry·Rosalie C Sears, Joseph R Nevins
Jun 1, 2002·Science·Lewis C Cantley
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Nov 2, 2002·Nature Medicine·Victor J DzauDaniel G Sedding
Feb 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Giuseppa GennaroAlain Rivard
Jul 23, 2004·Physiological Reviews·Gary K OwensBrian R Wamhoff
Sep 1, 2004·Circulation·Shiladitya SenguptaTai-Ping D Fan
Nov 19, 2004·Nature·Joan Massagué

❮ Previous
Next ❯

Citations

Feb 25, 2010·Cancer Prevention Research·Yu JinLorne J Hofseth
Dec 11, 2007·Canadian Journal of Physiology and Pharmacology·David D KittsChun Hu
Apr 5, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Jing HuangXie-Nan Huang
Feb 22, 2014·Journal of Ginseng Research·Min-Jung KimJoohun Ha
Sep 16, 2009·Environmental and Molecular Mutagenesis·Mark G MuellnerMichael J Plewa
Nov 9, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Kang XuXuefeng Qiu
Apr 21, 2020·Current Pharmaceutical Design·Mervin Chávez-CastilloManuel Velasco
May 9, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Guang-Xuan ZhuShu-Qing Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.